Regis Healthcare (FRA:06K1) Valuation Rank

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:06K1 Regis Healthcare Ltd FRA:06K1
56 GF Score
Price €3.70
GF Value €2.14
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Regis Healthcare Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Regis Healthcare Valuation Rank Related Terms

FRA:06K1
56GF Score
Regis Healthcare Ltd FRA:06K1
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Regis Healthcare (FRA:06K1) Overvalued in 2026?

Based on GuruFocus' analysis, Regis Healthcare stock appears to be overvalued. The current stock price of €3.70 is trading 72.9% above its estimated GF Value™ of €2.14. GuruFocus considers Regis Healthcare to be Significantly Overvalued.

Key valuation signals for FRA:06K1:

  • Valuation Rank:
  • GF Value™: €2.14 vs. price of €3.70 (72.9% above fair value)
  • GF Score™: 56/100 with 4 warning signs

No single metric tells the full story. See the FRA:06K1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Regis Healthcare Business Description

Other Exchanges REG:Australia
Address 293 Camberwell Road, Level 2, Camberwell, Melbourne, VIC, AUS, 3124
Regis Healthcare is an Australian residential aged care operator providing accommodation and care for individuals who require high levels of support due to health or mobility issues. Residents are typically over 85 years old and are typified by dementia, palliative care, incontinence, and falls risk. Regis also operates smaller retirement village and home care businesses.
56GF Score

Get the complete analysis for FRA:06K1

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.70
Price
€2.14
GF Value